HUNTER SYNDROME

Clinical trials for HUNTER SYNDROME explained in plain language.

Never miss a new study

Get alerted when new HUNTER SYNDROME trials appear

Sign up with your email to follow new studies for HUNTER SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 3 Completed 2

Lifelong enzyme therapy continues for hunter syndrome patients in Post-Trial access program

Disease control AVAILABLE

This program offers continued access to idursulfase-IT (TAK-609) given directly into the spinal fluid, along with intravenous Elaprase, for children and adults with Hunter syndrome who have cognitive impairment. Participants must have completed one of two earlier studies. The goa…

Matched conditions: HUNTER SYNDROME

Sponsor: Takeda • Aim: Disease control

Last updated May 14, 2026 12:03 UTC

HUNTER SYNDROME

Get alerted when new HUNTER SYNDROME trials appear

Lifelong enzyme therapy continues for hunter syndrome patients in Post-Trial access program